Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)28.07
  • Today's Change0.99 / 3.66%
  • Shares traded1.41m
  • 1 Year change-7.82%
  • Beta0.4980
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue4,6564,4524,139
OPERATING EXPENSES
Cost of revenue total2,9752,9962,723
Selling, general and admin. expenses, total1,2751,1631,071
Depreciation/amortization------
Unusual expense(income)12996231
Other operating expenses, total(0.8)3.00(418)
Total operating expense4,5014,3823,728
Operating income15570410
Other, net13(51)(24)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(8.3)(139)259
Provision for income taxes(3.9)(8.2)390
Net income after taxes(4.4)(131)(131)
Minority interest------
Net income before extra. Items(4.4)(131)(131)
Total extraordinary items(8.3)(9.7)62
Net income(13)(141)(69)
Inc.avail. to common excl. extra. Items(4.4)(131)(131)
Inc.avail. to common incl. extra. Items(13)(141)(69)
EPS RECONCILIATION
Basic/primary weighted average shares135135134
Basic/primary eps excl. extra items(0.03)(0.97)(0.98)
Basic/primary eps incl. extra items(0.09)(1.05)(0.52)
Dilution adjustment------
Diluted weighted average shares135135134
Diluted eps excl. extra items(0.03)(0.97)(0.98)
Diluted eps incl. extra items(0.09)(1.05)(0.52)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.091.040.96
Gross dividend - common stock150142130
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.60--0.80
SUPPLEMENTAL INCOME
Depreciation, supplemental9486102
Total special items12996231
NORMALISED INCOME
Normalized income before taxes121(43)490
Effect of special items on income taxes453481
Income tax excluding impact of special items4125470
Normalized income after tax79(68)19
Normalized income avail. to common79(68)19
Basic normalized EPS0.59(0.51)0.14
Diluted normalized EPS0.59(0.51)0.14
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.